Erlotinib Completed Phase 2 Trials for Renal Cell Adenocarcinoma / Metastases Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00081614A Study Evaluating Tarceva in Combination With Avastin Versus Avastin Alone in Treating Metastatic Renal Cell Carcinoma
NCT00353301Erlotinib and Sirolimus for the Treatment of Metastatic Renal Cell Carcinoma